Mogens Groenvold

Mogens Groenvold

Auto-generated profile, based on publicly available information

Mogens Groenvold

Palliative Care Research Unit, Bispebjerg and Frederiksberg Hospital, Copenhagen, Denmark; Department of Public Health, University of Copenhagen, Denmark

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2006 in European Journal of Cancer
Verified
Journal Article
Closed access
MGMogens Groenvold
Mogens Groenvold
MPMorten Aa. Petersen
Morten Aa. Petersen
NANeil K. Aaronson
Neil K. Aaronson
JAJuan I. Arraras
Juan I. Arraras
JBJane M. Blazeby
Jane M. Blazeby
JBJakob B. Bjorner
Jakob B. Bjorner

1 January 2016 in Journal of Clinical Epidemiology
Verified
Journal Article
Open access
JGJohannes M. Giesinger
Johannes M. Giesinger
JKJacobien M. Kieffer
Jacobien M. Kieffer
PFPeter M. Fayers
Peter M. Fayers
MGMogens Groenvold
Mogens Groenvold
MPMorten Aa. Petersen
Morten Aa. Petersen
NAN.K. Aaronson
N.K. Aaronson
To further evaluate the higher order measurement structure of the European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire Core 30 (QLQ-C30), with the aim of generating a summary score. Using pretreatment QLQ-C30 data (N = 3,282), we conducted confirmatory factor analyses to test seven previously evaluated higher order models. We compared the summary score(s) derived from the best performing higher order model with the original QLQ-C30 scale scores, using tumor stage, performance status, and change over time (N = 244) as grouping variables. Although all models showed acceptable fit, we continued in the interest of parsimony with known-groups validity and responsiveness analyses using a summary score derived from the single higher order factor model. The validity and responsiveness of this QLQ-C30 summary score was equal to, and in many cases superior to the original, underlying QLQ-C30 scale scores. Our results provide empirical support for a measurement model for the QLQ-C30 yielding a single summary score. The availability of this summary score can avoid problems with potential type I errors that arise because of multiple testing when making comparisons based on the 15 outcomes generated by this questionnaire and may reduce sample size requirements for health-related quality of life studies using the QLQ-C30 questionnaire when an overall summary score is a relevant primary outcome.

1 April 1997 in Journal of Clinical Epidemiology
Verified
Journal Article
Closed access
MGMogens Groenvold
Mogens Groenvold
MKMarianne Carol Klee
Marianne Carol Klee
MSMirjam A.G. Sprangers
Mirjam A.G. Sprangers
NANeil K. Aaronson
Neil K. Aaronson

1 February 2020 in Journal of Clinical Epidemiology
Verified
Journal Article
Open access
JGJohannes M. Giesinger
Johannes M. Giesinger
FLFanny L.C. Loth
Fanny L.C. Loth
NANeil K. Aaronson
Neil K. Aaronson
JAJuan I. Arraras
Juan I. Arraras
GCGiovanni Caocci
Giovanni Caocci
BHBernhard Holzner
Bernhard Holzner
The objective of this study was to establish thresholds for clinical importance (TCIs) for the five functioning and nine symptom scales of the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 (EORTC QLQ-C30). In this diagnostic study, cancer patients with mixed diagnoses and treatments completed the EORTC QLQ-C30 and anchored the questions in each domain in terms of their clinical importance. The anchor questions, concerned limitations in daily life, need for help/care, and the worries of the patient and his/her partner/family. These questions allowed categorizing patients into whether they exhibited a clinically important symptom/functional impairment for each scale and performing a receiver operating characteristic curve analysis to establish TCIs. Data from 498 patients from six European countries (mean age 60.4 years, 55.2% women) were analyzed. For the TCIs generated using the patient questionnaire data, the EORTC QLQ-C30 scales showed sensitivity values between 0.71 and 0.97 and specificity values between 0.62 and 0.92 (area under the curve above 0.80 for all scales). This EORTC Quality of Life Group study provides TCIs for the functioning and symptom scales of the EORTC QLQ-C30. These TCIs can increase the interpretability of the questionnaire results and foster its use in daily clinical practice and in clinical research.

3 January 2007 in Breast Cancer Research and Treatment
Verified
Journal Article
Closed access
PDF file
MGMogens Groenvold
Mogens Groenvold
MPMorten Aagaard Petersen
Morten Aagaard Petersen
EIEllen Idler
Ellen Idler
JBJakob Bue Bjorner
Jakob Bue Bjorner
PFPeter M. Fayers
Peter M. Fayers
HMHenning T. Mouridsen
Henning T. Mouridsen

1 July 2003 in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
Verified
Journal Article
Closed access
PJPernille Tine Jensen
Pernille Tine Jensen
MGMogens Groenvold
Mogens Groenvold
MKMarianne C Klee
Marianne C Klee
ITIngrid Thranov
Ingrid Thranov
MPMorten Aa Petersen
Morten Aa Petersen
DMDavid Machin
David Machin